The trial consisted of 37 patients with moderate-to-severe COPD, who received a single dose of either the drug or a placebo. More: Verona Pharma share positive ensifentrine results in COPD Source: News
read moreTecentriq was the first cancer immunotherapy approved in bladder cancer. More: Tecentriq, chemo combo shows bladder cancer promise Source: News
read moreThe trial was for patients six and older with the disease who required treatment with IV opioids for occlusive crisis. More: Rivipansel flunks Phase III sickle cell trial Source: News
read moreThe test can measure levels of the Alzheimer’s protein amyloid beta in the blood. More: New blood test ‘highly accurate’ at early Alzheimer’s identification Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals